G-5555 |
G-5555 : ATP competitive inhibitor of PAK1, PAK2, PAK3
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PAK1 |
|
|
| PAK2 |
|
|
| PAK3 |
|
|
ATP competitive
70 nM-250 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
IC50s:
SIK2: 9 nM
KHS1: 10 nM
MST4: 20 nM
MST3: 43 nM
YSK1: 34 nM
LCK: 52 nM
Selectivity Assessment Description:
5HT1B: 84% inhibition at 10 uM 5HT2B: 92% at 10 uM
Potency Cellular
In Vitro
PAK1
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? No
PAK2
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? No
PAK3
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? No
In Vivo Validations
Mouse
Dose: 10, 20, and 30 mg/kg
Route of delivery:
Oral
Plasma half life:
53 min
Systemic clearance:
24.2 mL/min/kg
Reference: --
Negative Control Compounds
(R)-6-(2-Chloro-4-(4-methyl-2-oxopyridin-1(2H)-yl)phenyl)- 2-(methylamino)-8-(morpholin-2-ylmethyl)pyrido[2,3-d]- pyrimidin-7(8H)-one
Chemical Information
| Molecular Formula | C25H25ClN6O3 |
| SMILEs | CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1 |
| InChI | InChI=1S/C25H25ClN6O3/c1-14-4-3-5-21(30-14)15-6-7-18(20(26)9-15)19-8-16-10-29-25(28-2)31-23(16)32(24(19)33)11-22-34-12-17(27)13-35-22/h3-10,17,22H,11-13,27H2,1-2H3,(H,28,29,31)/t17-,22- |
| Molecular weight | 492.17 Da |
| AlogP | 0.0 |
| HBond acceptors | 9 |
| HBond donors | 3 |
| Atoms | 60 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.